Constance Care (WAR:CCR) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:CCR Constance Care SA WAR:CCR
22 GF Score
Price zł5.20
GF Value zł0.15
Valuation Significantly Overvalued
View Full Analysis

What is Constance Care Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

WAR:CCR
22GF Score
Constance Care SA WAR:CCR
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Constance Care (WAR:CCR) Overvalued in 2026?

Based on GuruFocus' analysis, Constance Care stock appears to be overvalued. The current stock price of zł5.20 is trading 3366.7% above its estimated GF Value™ of zł0.15. GuruFocus considers Constance Care to be Significantly Overvalued.

Key valuation signals for WAR:CCR:

  • Dividends Received:
  • GF Value™: zł0.15 vs. price of zł5.20 (3366.7% above fair value)
  • GF Score™: 22/100

No single metric tells the full story. See the WAR:CCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Constance Care Business Description

Address ul. Dzialkowa 125, Kierszek, POL, 05-500
Constance Care SA conducts physiotherapeutic activities aimed at improving the quality of health and life of people suffering both from musculoskeletal disorders as a result of various random events, diseases or related to the aging of the body, as well as the rehabilitation of cognitive functions in children and adults.
22GF Score

Get the complete analysis for WAR:CCR

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł5.20
Price
zł0.15
GF Value